Cargando…

Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy

BACKGROUND: Statin‐mediated efficacy of lowering low‐density lipoprotein (LDL) cholesterol varies in each individual, and its diminished response is associated with worse outcomes. However, there is no established approach to predict hyporesponse to statins. PCSK9 (proprotein convertase subxilisin/k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuyama, Naoto, Kataoka, Yu, Takegami, Misa, Nishimura, Kunihiro, Harada‐Shiba, Mariko, Hori, Mika, Ogura, Masatsune, Otsuka, Fumiyuki, Asaumi, Yasuhide, Noguchi, Teruo, Tsujita, Kenichi, Yasuda, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483520/ https://www.ncbi.nlm.nih.gov/pubmed/33998287 http://dx.doi.org/10.1161/JAHA.120.019525

Ejemplares similares

Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
por: Doi, Takahito, et al.
Publicado: (2021)

Multi-modality imaging of high-intensity plaques on non-contrast T1-weighted magnetic resonance imaging: a case report
por: Hosoda, Hayato, et al.
Publicado: (2023)

Refractory In-Stent Restenosis Attributable to Eruptive Calcified Nodule
por: Nakano, Hiroki, et al.
Publicado: (2020)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels
por: Funabashi, Sayaka, et al.
Publicado: (2022)

Thyroid Storm Patients With Elevated Brain Natriuretic Peptide Levels and Associated Left Ventricular Dilatation May Require Percutaneous Mechanical Support
por: Arai, Marina, et al.
Publicado: (2021)

Noninvasive Coronary Plaque Imaging
por: Noguchi, Teruo, et al.
Publicado: (2018)

Optical coherence tomography-verified morphological correlates of high-intensity coronary plaques on non-contrast T1-weighted magnetic resonance imaging in patients with stable coronary artery disease
por: Kanaya, Tomoaki, et al.
Publicado: (2019)

COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction
por: Kitahara, Satoshi, et al.
Publicado: (2021)

Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society
por: Funabashi, Sayaka, et al.
Publicado: (2021)

Continuous improvement of both hepatic and cardiac dysfunction by sequential plasma exchange in a patient with thyrotoxicosis and cardiogenic shock: a case report indicating the potential role of cardiohepatic interactions during thyroid storm
por: Suzuki, Toshiaki, et al.
Publicado: (2022)

Case report: a potential modulation of coronary atheroma by lowering triglyceride-rich lipoproteins with pemafibrate: insights from serial near-infrared spectroscopy imaging
por: Murata, Yu, et al.
Publicado: (2023)

Prospective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design
por: Tada, Hayato, et al.
Publicado: (2022)

Characterization of plaque phenotypes exhibiting an elevated pericoronary adipose tissue attenuation: insights from the REASSURE-NIRS registry
por: Kitahara, Satoshi, et al.
Publicado: (2023)

Heart‐Brain Team Approach of Acute Myocardial Infarction Complicating Acute Stroke: Characteristics of Guideline‐Recommended Coronary Revascularization and Antithrombotic Therapy and Cardiovascular and Bleeding Outcomes
por: Suzuki, Toshiaki, et al.
Publicado: (2023)

Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
por: Kataoka, Yu, et al.
Publicado: (2021)

Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention
por: Hosoda, Hayato, et al.
Publicado: (2020)

Correction to: Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention
por: Hosoda, Hayato, et al.
Publicado: (2020)

The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
por: Hori, Mika, et al.
Publicado: (2020)

Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapy
por: Hayashi, Hiroya, et al.
Publicado: (2022)

A Resuscitated Case of Acute Myocardial Infarction with both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 Deficiency
por: Nishikawa, Ryo, et al.
Publicado: (2022)

Predicting Parameters for Successful Weaning from Veno‐Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock
por: Sawada, Kenichiro, et al.
Publicado: (2020)

Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial Hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation
por: Shirahama, Ryo, et al.
Publicado: (2018)

Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments
por: Koyama, Shingo, et al.
Publicado: (2021)

Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia
por: Michikura, Masahito, et al.
Publicado: (2022)

Multipolar catheter entrapment in a mechanical mitral valve and successful retrieval of a sheared spine straying into the coronary artery
por: Asahina, Chisa, et al.
Publicado: (2022)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

Gradual dose Titration of Lomitapide may Prevent Therapeutic Delays in Patients with Homozygous Familial Hypercholesterolemia
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene
por: Tada, Hayato, et al.
Publicado: (2022)

Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial
por: Nakao, Kazuhiro, et al.
Publicado: (2018)

Trends in the Clinical and Pathological Characteristics of Cardiac Rupture in Patients With Acute Myocardial Infarction Over 35 Years
por: Honda, Satoshi, et al.
Publicado: (2014)

Rationale, Design, and Baseline Characteristics of the Prospective Japan Acute Myocardial Infarction Registry (JAMIR)
por: Honda, Satoshi, et al.
Publicado: (2018)

Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
por: Choi, Jah Yeon, et al.
Publicado: (2019)

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
por: LaFratte, Christopher, et al.
Publicado: (2023)

Cholesterol-crystalized coronary atheroma as a potential precursor lesion causing acute coronary syndrome: a case report
por: Sugane, Hiroki, et al.
Publicado: (2019)

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD
por: Hosoda, Hayato, et al.
Publicado: (2023)

Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure
por: Nagai, Toshiyuki, et al.
Publicado: (2016)

Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia
por: Kitajima, Ryota, et al.
Publicado: (2017)

Impact of Different Therapeutic Strategies With Left Ventricular Assist Devices on Health-Related Quality of Life During Prolonged Device-Based Support
por: Asase, Mariko, et al.
Publicado: (2023)

Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
por: Mayne, Janice, et al.
Publicado: (2008)

Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
por: Sliz, Eeva, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6p5a35rmj70mlmle6kl7frtks4